Mereo BioPharma Group plc - American Depositary Shares (NQ:MREO)

0.4228 +0.0018 (+0.43%)

Streaming Delayed Price Updated: 11:11 AM EST, Feb 19, 2026 Add to My Watchlist

Price and Volume

Volume	879,146
Open	0.4221
Bid (Size)	0.4195 (700)
Ask (Size)	0.4226 (500)
Prev. Close	0.4210
Today's Range	0.4086 - 0.4300
52wk Range	0.2000 - 3.050
Shares Outstanding	584,908,239
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

MREO INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026

Today 9:42 EST

From Faruqi & Faruqi LLP

Via GlobeNewswire

Stockholders Who Lost Money Investing in Mereo BioPharma Group plc Should Contact Robbins LLP for Information About Recovering Their Losses from MREO

February 18, 2026

From Robbins LLP

Via GlobeNewswire

Performance

YTD	-17.2%	-17.2%
1 Month	-25.2%	-25.2%
3 Month	-76.6%	-76.6%
6 Month	-74.1%	-74.1%
1 Year	-85.4%	-85.4%

More News

CLASS ACTION ALERTS: Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ultragenyx and Mereo BioPharma and Encourages Investors to Contact the Firm

February 17, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines – MREO

February 17, 2026

From Pomerantz LLP

Via GlobeNewswire

MREO SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds Mereo (MREO) Investors of Securities Class Action Deadline on April 6, 2026

February 14, 2026

From Faruqi & Faruqi LLP

Via GlobeNewswire

MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm

February 13, 2026

From Schall Law

Via GlobeNewswire

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Mereo BioPharma Group plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – MREO

February 13, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm

February 10, 2026

From Schall Law

Via GlobeNewswire

MREO Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Mereo BioPharma Group plc Class Action

February 09, 2026

From Robbins LLP

Via GlobeNewswire

ATTENTION NASDAQ: MREO INVESTORS: Contact Berger Montague About a Mereo BioPharma Group PLC Class Action Lawsuit

February 09, 2026

From Berger Montague

Via GlobeNewswire

ROSEN, LEADING INVESTOR COUNSEL, Encourages Mereo BioPharma Group plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – MREO

February 07, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

Mereo BioPharma Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – MREO

February 06, 2026

From DJS Law Group

Via Business Wire

MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm

February 05, 2026

From The Schall Law Firm

Via Business Wire

MEREO LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Mereo BioPharma Group plc and Encourages Investors to Contact the Firm

February 05, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Mereo BioPharma

February 05, 2026

From Faruqi & Faruqi LLP

Via GlobeNewswire

Rosen Law Firm Urges Mereo BioPharma Group plc (NASDAQ: MREO) Stockholders to Contact the Firm for Information About Their Rights

February 05, 2026

From The Rosen Law Firm, P.A.

Via Business Wire

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the Mereo BioPharma Group plc Securities Class Action Lawsuit

February 04, 2026

From Robbins LLP

Via Business Wire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Mereo BioPharma Group plc – MREO

February 03, 2026

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO

January 27, 2026

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO

January 20, 2026

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO

January 13, 2026

From Pomerantz LLP

Via GlobeNewswire

Curious about the stocks that are showing activity after the closing bell on Monday? ↗

January 12, 2026

Via Chartmill

Keep an eye on the top gainers and losers in Monday's session. ↗

January 12, 2026

Via Chartmill

Mereo BioPharma Provides Corporate Update

January 12, 2026

From Mereo BioPharma Group plc

Via GlobeNewswire

Top movers analysis one hour before the close of the markets on 2026-01-06: top gainers and losers in today's session. ↗

January 06, 2026

Via Chartmill

Frequently Asked Questions

Is Mereo BioPharma Group plc - American Depositary Shares publicly traded?

Yes, Mereo BioPharma Group plc - American Depositary Shares is publicly traded.

What exchange does Mereo BioPharma Group plc - American Depositary Shares trade on?

Mereo BioPharma Group plc - American Depositary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Mereo BioPharma Group plc - American Depositary Shares?

The ticker symbol for Mereo BioPharma Group plc - American Depositary Shares is MREO on the Nasdaq Stock Market

What is the current price of Mereo BioPharma Group plc - American Depositary Shares?

The current price of Mereo BioPharma Group plc - American Depositary Shares is 0.4228

When was Mereo BioPharma Group plc - American Depositary Shares last traded?

The last trade of Mereo BioPharma Group plc - American Depositary Shares was at 02/19/26 11:11 AM ET

What is the market capitalization of Mereo BioPharma Group plc - American Depositary Shares?

The market capitalization of Mereo BioPharma Group plc - American Depositary Shares is 247.30M

How many shares of Mereo BioPharma Group plc - American Depositary Shares are outstanding?

Mereo BioPharma Group plc - American Depositary Shares has 247M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.